Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn J Bubley

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
The challenge of herbal therapies for prostate cancerRupal S Bhatt, Glenn J Bubley
Bioorganic & Medicinal Chemistry Letters|September 15, 2006
Microwave expedited synthesis of 5-aminocamptothecin analogs: Inhibitors of hypoxia inducible factor HIF-1alphaJoelle Torregrossa, Glenn J Bubley, Graham B Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Biology of prostate-specific antigenSteven P Balk, Yoo-Joung Ko, Glenn J Bubley
Cancer Research|December 4, 2012
Clonal progression of prostate cancers from Gleason grade 3 to grade 4Adam G Sowalsky, Huihui Ye, Glenn J Bubley, et al.
The Prostate|November 13, 2004
Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradationXinyu S Fu, Eunis Choi, Glenn J Bubley, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2006
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1Shaoyong Chen, Youyuan Xu, Xin Yuan, et al.
The Journal of Urology|July 4, 2006
The effect of androgen deprivation therapy on fasting serum lipid and glucose parametersJennifer Yannucci, Judi Manola, Marc B Garnick, et al.
The Journal of Biological Chemistry|May 17, 2002
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptorDavid Masiello, Shinta Cheng, Glenn J Bubley, et al.
Urology|March 16, 2013
Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapyGlenn J Bubley, B N Bloch, Cesar Vazquez, et al.
International Journal of Cancer|September 30, 2004
Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibitionJaime R Merchan, Deepa R Jayaram, Jeffrey G Supko, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
The challenge of herbal therapies for prostate cancerRupal S Bhatt, Glenn J Bubley
Bioorganic & Medicinal Chemistry Letters|September 15, 2006
Microwave expedited synthesis of 5-aminocamptothecin analogs: Inhibitors of hypoxia inducible factor HIF-1alphaJoelle Torregrossa, Glenn J Bubley, Graham B Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Biology of prostate-specific antigenSteven P Balk, Yoo-Joung Ko, Glenn J Bubley
Cancer Research|December 4, 2012
Clonal progression of prostate cancers from Gleason grade 3 to grade 4Adam G Sowalsky, Huihui Ye, Glenn J Bubley, et al.
The Prostate|November 13, 2004
Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradationXinyu S Fu, Eunis Choi, Glenn J Bubley, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2006
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1Shaoyong Chen, Youyuan Xu, Xin Yuan, et al.
The Journal of Urology|July 4, 2006
The effect of androgen deprivation therapy on fasting serum lipid and glucose parametersJennifer Yannucci, Judi Manola, Marc B Garnick, et al.
The Journal of Biological Chemistry|May 17, 2002
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptorDavid Masiello, Shinta Cheng, Glenn J Bubley, et al.
Urology|March 16, 2013
Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapyGlenn J Bubley, B N Bloch, Cesar Vazquez, et al.
International Journal of Cancer|September 30, 2004
Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibitionJaime R Merchan, Deepa R Jayaram, Jeffrey G Supko, et al.
Pageof 7